ATC Group: J05AR27 Lamivudine, tenofovir disoproxil and dolutegravir

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J05AR27 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J05 Antivirals for systemic use
3 J05A Direct acting antivirals
4 J05AR Antivirals for treatment of HIV infections, combinations
5 J05AR27

Related product monographs

Document Type Information Source  
 ACRIPTEGA Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)
 DOLTELAM Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)
 ENVUTEG Tablet MPI, Generic Health Products Regulatory Authority (ZA)
 KOVATRAX Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)
 LANOGRAV Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)
 LAVEM Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)
 REYDIN Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)
 TELADO Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)
 TELATRI Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)
 VOLUTRIP Film-coated tablet MPI, Generic Health Products Regulatory Authority (ZA)

Medicines classified under this ATC code globally

Nigeria (NG)

South Africa (ZA)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.